Overview

Effect of Somatropin on Left Ventricular Mass in Growth Hormone Deficient Adult Patients

Status:
Completed
Trial end date:
2002-12-01
Target enrollment:
Participant gender:
Summary
This trial is conducted in Europe. The aim of this trial is to assess the effect of somatropin (Norditropin®) replacement therapy on the left ventricular mass of adult patients with a growth hormone deficiency.
Phase:
Phase 4
Details
Lead Sponsor:
Novo Nordisk A/S
Treatments:
Hormones